A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma

Title
A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed Glioblastoma
Authors
Keywords
-
Journal
CLINICAL CANCER RESEARCH
Volume 22, Issue 19, Pages 4776-4785
Publisher
American Association for Cancer Research (AACR)
Online
2016-05-26
DOI
10.1158/1078-0432.ccr-16-0506

Ask authors/readers for more resources

Discover Peeref hubs

Discuss science. Find collaborators. Network.

Join a conversation

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now